Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 11, 2009
Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003: implications for cancer control
Elizabeth A Tracey, David M Roder, Jane Francis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer
Anish Bali, Philippa M O'Brien, Lyndal S Edwards, et al.
Cancer Management and Research
|
November 10, 2018
Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers
Céline Montavon Sartorius, Uzma Mirza, Andreas Schötzau, et al.
Gynecologic Oncology
|
October 17, 2020
Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasis
Jacobus van der Velden, Noortje Pleunis, Ellen Barlow, et al.
Journal of Ovarian Research
|
February 12, 2017
Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients
Tatiana Pochechueva, Shahidul Alam, Andreas Schötzau, et al.
Obstetrics and Gynecology
|
May 3, 2013
Primary surgical management with tailored adjuvant radiation for stage IB2 cervical cancer
Neville F Hacker, Ellen L Barlow, James Scurry, et al.
Plos One
|
October 21, 2016
Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients
Tatiana Pochechueva, Alexander Chinarev, Andreas Schoetzau, et al.
Plos One
|
March 30, 2018
ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer
Céline Montavon Sartorius, Andreas Schoetzau, Henriette Kettelhack, et al.
BMC Molecular Biology
|
October 9, 2014
Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells
Francis Jacob, Megan P Hitchins, André Fedier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 14, 2016
Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting
Gwendolin Manegold-Brauer, Johanna Buechel, Alexandra Knipprath-Mészaros, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 11, 2009
Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003: implications for cancer control
Elizabeth A Tracey, David M Roder, Jane Francis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer
Anish Bali, Philippa M O'Brien, Lyndal S Edwards, et al.
Cancer Management and Research
|
November 10, 2018
Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers
Céline Montavon Sartorius, Uzma Mirza, Andreas Schötzau, et al.
Gynecologic Oncology
|
October 17, 2020
Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasis
Jacobus van der Velden, Noortje Pleunis, Ellen Barlow, et al.
Journal of Ovarian Research
|
February 12, 2017
Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients
Tatiana Pochechueva, Shahidul Alam, Andreas Schötzau, et al.
Obstetrics and Gynecology
|
May 3, 2013
Primary surgical management with tailored adjuvant radiation for stage IB2 cervical cancer
Neville F Hacker, Ellen L Barlow, James Scurry, et al.
Plos One
|
October 21, 2016
Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients
Tatiana Pochechueva, Alexander Chinarev, Andreas Schoetzau, et al.
Plos One
|
March 30, 2018
ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer
Céline Montavon Sartorius, Andreas Schoetzau, Henriette Kettelhack, et al.
BMC Molecular Biology
|
October 9, 2014
Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells
Francis Jacob, Megan P Hitchins, André Fedier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 14, 2016
Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting
Gwendolin Manegold-Brauer, Johanna Buechel, Alexandra Knipprath-Mészaros, et al.
Page
of 7